期刊文献+
共找到13篇文章
< 1 >
每页显示 20 50 100
新型冠状病毒疫苗研发进展和思考 被引量:13
1
作者 孙校金 王富珍 +2 位作者 安志杰 lance rodewald 尹遵栋 《中国疫苗和免疫》 北大核心 2020年第3期344-348,共5页
2019年底中国武汉发生2019冠状病毒病(Coronavirus disease 2019,COVID-19)暴发疫情。2020年1月30日WHO宣布将该疫情列为国际关注的突发公共卫生事件,3月12日宣布为大流行。截至2020年4月3日,全球报告972303例COVID-19确诊病例,死亡5032... 2019年底中国武汉发生2019冠状病毒病(Coronavirus disease 2019,COVID-19)暴发疫情。2020年1月30日WHO宣布将该疫情列为国际关注的突发公共卫生事件,3月12日宣布为大流行。截至2020年4月3日,全球报告972303例COVID-19确诊病例,死亡50321例;其中中国报告82802例,死亡3331例。为应对COVID-19疫情进一步传播,多国已宣布启动COVID-19疫苗研发工作。本文综述了全球COVID-19疫苗研发的初步进展,并对疫苗研发和使用提出相关建议。 展开更多
关键词 2019冠状病毒病 新型冠状病毒 疫苗
原文传递
中国消除麻疹的关键技术问题:专家解读共识 被引量:138
2
作者 苏琪茹 徐爱强 +27 位作者 Peter Strebel 许文波 郝利新 周勇 李慧 庞星火 马超 张燕 方刚 崔富强 丁峥嵘 沈永刚 安志杰 张永基 谢淑云 William Schluter 余文周 郑景山 夏伟 王青 郑慧贞 张延炀 张丽杰 段梦娟 杨维中 lance rodewald 李黎 罗会明 《中国疫苗和免疫》 CAS 2014年第3期264-270,283,共8页
中国卫生部发布《2006—2012年全国消除麻疹行动计划》以来,全国采取了一系列消除麻疹策略与措施并取得明显进展,但中国处于消除麻疹的关键时期,面临着新的挑战,麻疹流行病学特征也发生了变化,尤其需要统一和澄清对一些技术问题的... 中国卫生部发布《2006—2012年全国消除麻疹行动计划》以来,全国采取了一系列消除麻疹策略与措施并取得明显进展,但中国处于消除麻疹的关键时期,面临着新的挑战,麻疹流行病学特征也发生了变化,尤其需要统一和澄清对一些技术问题的认识。中国疾病预防控制中心(Center for Disease Control and Prevention,CDC)免疫规划中心收集、汇总各级CDC专业人员近年来关注的问题,并会同世界卫生组织驻华代表处,组织国内外专家深人研讨了主要的技术问题,包括消除麻疹与接种疫苗、麻疹病例的传染来源、保护〈8月龄婴儿、爆发疫情的应急免疫活动、医院传播的作用和控制意义、特殊人群及场所等,形成专家解读共识,供相关部门和专业人员在消除麻疹中参考。 展开更多
关键词 消除麻疹 共识
原文传递
中国推进消灭脊髓灰质炎终结战略计划技术问题:世界卫生组织专家解读 被引量:9
3
作者 左树岩 lance rodewald +3 位作者 Roland Sutter Jackie Fournier-Caruana William Schluter Sergey Diorditsa 《中国疫苗和免疫》 北大核心 2015年第4期439-443,共5页
中国积极推进消灭脊髓灰质炎(脊灰)终结战略计划,分阶段将灭活脊灰病毒疫苗(Inactivated Poliovirus Vaccine,IPV)纳入免疫规划,预期2016年4月与全球同步停服三价(Trivalent)口服脊灰减毒活疫苗(Oral Poliomyelitis Attenuated Live Vac... 中国积极推进消灭脊髓灰质炎(脊灰)终结战略计划,分阶段将灭活脊灰病毒疫苗(Inactivated Poliovirus Vaccine,IPV)纳入免疫规划,预期2016年4月与全球同步停服三价(Trivalent)口服脊灰减毒活疫苗(Oral Poliomyelitis Attenuated Live Vaccine,t OPV),开始接种二价(Bivalent)OPV(b OPV)。为澄清对一些技术问题的认识,世界卫生组织驻中国代表处会同国内外相关专家,讨论了中国部分专业人员提出的主要技术和政策问题,包括停用OPV的原因,b OPV替代t OPV使用的步骤,转换前减少风险的准备等,形成专家解读,供相关部门和专业人员在推进消灭脊灰终结战略计划中参考。 展开更多
关键词 消灭脊髓灰质炎 终结战略计划 脊髓灰质炎疫苗转换
原文传递
以疫苗接种提高人群免疫力来巩固中国成功遏制新型冠状病毒肺炎疫情的策略与挑战 被引量:1
4
作者 安志杰 王富珍 +5 位作者 潘安 尹遵栋 lance rodewald 冯子健 胡莹雪 张琳(译) 《英国医学杂志中文版》 2022年第4期208-211,共4页
冯子健及其同事认为在中国持续消除新型冠状病毒肺炎(COVID‑19)本土病例,为新冠病毒疫苗接种政策提供了灵活性,并讨论了预期的挑战,以及开展系统性监测的必要性,以使疫情应对措施中预防接种的部分保持在正确的轨道上。新型冠状病毒(以... 冯子健及其同事认为在中国持续消除新型冠状病毒肺炎(COVID‑19)本土病例,为新冠病毒疫苗接种政策提供了灵活性,并讨论了预期的挑战,以及开展系统性监测的必要性,以使疫情应对措施中预防接种的部分保持在正确的轨道上。新型冠状病毒(以下简称新冠病毒)在中国的流行不同寻常,但也并非独一无二。通过实施全民参与的强有力的非药物干预措施,新冠病毒在2020年4月得到了有效遏制1。从疫情暴发开始就采取的总体政策是(现在依然是)“本土传播零容忍”。成功地维持18个月只发生2例新冠病毒肺炎死亡病例(图1)。零容忍政策具有的重大意义在于持续消除新冠病毒本土流行和中国新冠病毒疫苗接种策略。 展开更多
关键词 疫苗接种 预防接种 人群免疫力 肺炎 全民参与 零容忍 疫情 应对措施
原文传递
新型冠状病毒肺炎疫情紧急研究议程:传播和非药物缓疫策略 被引量:35
5
作者 中国疾病预防控制中心新型冠状病毒肺炎疫情防控技术组 冯子健 +18 位作者 陈秋兰 冯录召 李中杰 黎舒 秦颖 王晴 杨孝坤 殷文武 张慕丽 张婷 安志杰 李媛秋 吴丹 尹遵栋 俞海亮 陈伟 夏愔愔 张若尘 lance rodewald 《中华流行病学杂志》 CAS CSCD 北大核心 2020年第2期135-138,共4页
2019年12月29日,武汉市某医院报告了一起不明原因重症肺炎聚集性病例事件,中国政府核实后通报了世界卫生组织(WHO)[1]。2020年1月8日,此次暴发的病原被确认为新型冠状病毒,即2019新型冠状病毒(2019-nCoV),其基因序列被迅速提交WHO。1月3... 2019年12月29日,武汉市某医院报告了一起不明原因重症肺炎聚集性病例事件,中国政府核实后通报了世界卫生组织(WHO)[1]。2020年1月8日,此次暴发的病原被确认为新型冠状病毒,即2019新型冠状病毒(2019-nCoV),其基因序列被迅速提交WHO。1月30日,WHO宣布将新型冠状病毒感染的肺炎疫情列为"国际关注的突发公共卫生事件"[2]。病原确认后的1个月中,科学家们通过研究已经阐述了诸多重要问题,给疫情的理解、预测和防控带来很多帮助[1,3,4,5,6,7]。尽管我们对2019-nCoV的认识已逐步深入,但很多问题仍然缺乏答案或不够精确,亟待解决。 展开更多
关键词 冠状病毒感染 突发公共卫生事件 肺炎 疫情 不明原因 研究议程
原文传递
Effectiveness of Catch-Up Vaccinations after COVID-19 Containment--China,2020 被引量:7
6
作者 Jing Wu Wenzhou Yu +19 位作者 Lei Cao Lingsheng Cao lance rodewald Jiakai Ye Yifan Song Li Li Xiaoxue Liu Ning Wen Fuzhen Wang Lixin Hao Yixing Li Hui Zheng Keli Li Chao Ma Dan Wu Yanmin Liu Guomin Zhang Zhijie An Huaqing Wang Zundong Yin 《China CDC weekly》 2020年第50期968-974,共7页
Introduction:In the early stages of the coronavirus disease 2019(COVID-19)epidemic in China,the highest level of public health emergency response(Level 1 Response)was launched in all province-level administrative divi... Introduction:In the early stages of the coronavirus disease 2019(COVID-19)epidemic in China,the highest level of public health emergency response(Level 1 Response)was launched in all province-level administrative divisions(PLADs)across the country.Provision of vaccination services was selectively suspended due to the physical distancing and gathering restrictions required of Level 1 Response.The purpose of this paper is to evaluate the impact of COVID-19 on vaccination services and the effectiveness of selective vaccination service suspension and catch-up vaccinations in China.Methods:Vaccine doses administered,routine vaccination coverage levels,catch-up vaccine doses administered,and coverage levels after the catch-up campaign were determined from individual vaccination records in sampled clinics,standard routine immunization administrative coverage reports,and catch-up vaccination activity reports submitted by PLADs between October 2019 and October 2020.Results:National Immunization Program(NIP)and non-NIP vaccine doses administered in sampled clinics decreased by 80% and 90%,respectively,compared with doses administered before the COVID-19 pandemic.Coverage with the birth dose of hepatitis B vaccine(HepB1)and the Bacillus Calmette-Guérin vaccine(BCG)—two vaccinations recommended to continue throughout the epidemic due to their timecritical nature—were maintained at over 85%,while coverage of other NIP vaccines decreased to below 60%by February 2020.Catch-up vaccination coverage of the 29 PLADs,excluding Xinjiang and Xizang(Tibet),began in April 2020 and exceeded 90%;Hubei catch-up coverage was 95% by October 2020.Conclusions and Implications for Public Health Practice:The COVID-19 pandemic had a great impact on China’s vaccination services.During the epidemic and time of local transmission of the coronavirus,HepB1,BCG,rabies vaccine for postexposure prophylaxis,and tetanus antitoxin(TAT)for wound prophylaxis were maintained at high levels.Of the 69 million vaccine doses postponed during the time of local transmission of the coronavirus,94% were administered in the catch-up campaign.China’s pandemic immunization practices may provide evidence for other countries’immunization programs. 展开更多
关键词 doses ROUTINE maintained
原文传递
The National Immunization Advisory Committee in China:Roles of National Experts in Making Evidence-Based Recommendations for Immunization 被引量:5
7
作者 Chao Ma lance rodewald +2 位作者 Zhijie An Zundong Yin Zijian Feng 《China CDC weekly》 2019年第2期28-30,共3页
In 2017,the State Council requested the National Health and Family Planning Commission(NHFPC),known as the Ministry of Health(MoH)before 2013 and as the National Health Commission(NHC)after 2018,to establish China’s ... In 2017,the State Council requested the National Health and Family Planning Commission(NHFPC),known as the Ministry of Health(MoH)before 2013 and as the National Health Commission(NHC)after 2018,to establish China’s National Immunization Advisory Committee(NIAC)(1).The NIAC acts as China’s National Immunization Technical Advisory Group(NITAG)—a deliberative body of national experts who advise national authorities and policy makers with evidence-based recommendations on immunization policy and program(2-3). 展开更多
关键词 POLICY RECOMMENDATIONS authorities
原文传递
Progress Toward Measles Elimination--China,January 2013-June 2019 被引量:4
8
作者 Chao Ma lance rodewald +10 位作者 Lixin Hao Qiru Su Yan Zhang Ning Wen Chunxiang Fan Hong Yang Huiming Luo Huaqing Wang James LGoodson Zundong Yin Zijian Feng 《China CDC weekly》 2019年第2期21-25,共5页
What is already known about this topic?China has historically had high measles incidence and many associated deaths.A comprehensive measles elimination plan during 2006-2012 substantially reduced measles incidence;how... What is already known about this topic?China has historically had high measles incidence and many associated deaths.A comprehensive measles elimination plan during 2006-2012 substantially reduced measles incidence;however,a resurgence occurred during 2013-2015.What is added by this report?In China,measles surveillance,outbreak response,research,and program evaluation were used to strengthen routine immunization and target immunization activities for eliminating measles.Measles incidence declined from 31 per million in 2015 to 2.8 in 2018;only one measles-associated death has been reported during 2018-June 2019.What are the implications for public health practice?The World Health Organization-recommended strategy to eliminate measles can be effective,including in large,densely populated countries like China. 展开更多
关键词 MEASLES ROUTINE eliminate
原文传递
Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2(Delta)Variant 被引量:3
9
作者 Fuzhen Wang Zhijie An +6 位作者 lance rodewald Dan Wu Lin Tang Hui Zheng Qianqian Liu George F.Gao Zundong Yin 《China CDC weekly》 2021年第34期728-730,共3页
Guangdong CDC published in preprint a critically important study of the effectiveness of China’s inactivated vaccines against the B.1.617.2(Delta)variant of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)... Guangdong CDC published in preprint a critically important study of the effectiveness of China’s inactivated vaccines against the B.1.617.2(Delta)variant of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)—a strain of the virus that causes coronavirus disease 2019(COVID-19)and is circulating globally(1–2).The Delta variant managed to get through China’s strong international border quarantine protection and spark an outbreak in Guangdong Province in May–June 2021.While the outbreak was being stopped using guidance of the Protocol for Prevention and Control of COVID-19(3),the investigators took advantage of provisions in the Protocol that identified close contacts of anyone infected with SARS-CoV-2。 展开更多
关键词 DELTA GUANGDONG globally
原文传递
Vaccinate with Confidence and Finish Strong 被引量:2
10
作者 lance rodewald Dan Wu +1 位作者 Zundong Yin Zijian Feng 《China CDC weekly》 2022年第37期828-831,共4页
China’s sustained containment of the coronavirus disease 2019(COVID-19)epidemic has spared over 99%of the mainland of China’s 1.4 billion people from exposure to and infection with severe acute respiratory syndrome ... China’s sustained containment of the coronavirus disease 2019(COVID-19)epidemic has spared over 99%of the mainland of China’s 1.4 billion people from exposure to and infection with severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and its variants for an astonishing two and a half years.Although the whole-of-government,whole-of-society containment effort has its own socioeconomic costs,the now-called dynamic COVID-zero strategy purchased a rare commodity—tranquil time with relatively little suffering and death from COVID-19 to develop and deploy tools for escaping the pandemic:diagnostics,vaccines,antivirals,and knowledge(1). 展开更多
关键词 CONFIDENCE SUSTAINED ACUTE
原文传递
Vaccination Guidelines During and After the COVID-19 Epidemic in China 被引量:1
11
作者 Wenzhou Yu Yuanqiu Li +18 位作者 Jing Wu Fuzhen Wang Ning Wen lance rodewald Lixin Hao Yixing Li Hui Zheng Keli Li Chao Ma Dan Wu Lei Cao Lingsheng Cao Jiakai Ye Yanmin Liu Guomin Zhang Wen Du Zhijie An Huaqing Wang Zundong Yin 《China CDC weekly》 2020年第34期661-665,共5页
In late December 2019,clinicians in Hubei Province noticed and reported to health authorities a cluster of cases of pneumonia of unknown etiology(PUE)that turned out to be the start of the coronavirus disease 2019(COV... In late December 2019,clinicians in Hubei Province noticed and reported to health authorities a cluster of cases of pneumonia of unknown etiology(PUE)that turned out to be the start of the coronavirus disease 2019(COVID-19)pandemic(1).By January 29,2020,all provincial-level administrative divisions(PLADs)across the country had launched their highest public health emergency responses(Level 1 responses)(2-3). 展开更多
关键词 authorities ADMINISTRATIVE COV
原文传递
Senior Research Scholars in China CDC’s National Immunization Program
12
作者 Miao Wang Yanmin Liu +3 位作者 Tingting Yan lance rodewald Zhijie An Zundong Yin 《China CDC weekly》 2021年第43期911-913,共3页
China CDC’s National Immunization Program’s Senior Research Scholars Program(NIP-SRSP)is a program created to foster the professional development of early-to-mid-career immunization experts,strengthen knowledge exch... China CDC’s National Immunization Program’s Senior Research Scholars Program(NIP-SRSP)is a program created to foster the professional development of early-to-mid-career immunization experts,strengthen knowledge exchange and cooperation between national and provincial/prefectural-level CDCs,and deepen scientific and programmatic capacity of the National Immunization Program and provincial/prefectural immunization programs.Initiated in September 2019. 展开更多
关键词 PROGRAM CDC PROVINCIAL
原文传递
“If the world doesn’t share the vaccine,the virus will take on the world”
13
作者 Zundong Yin lance rodewald Dan Wu 《China CDC weekly》 2021年第13期265-266,共2页
What did George Gao mean by the title quote?The statement certainly feels like a warning,but it is a warning that comes with a prescription that carries optimism and hope.The warning that the virus will“take on the w... What did George Gao mean by the title quote?The statement certainly feels like a warning,but it is a warning that comes with a prescription that carries optimism and hope.The warning that the virus will“take on the world”has indeed been the world’s experience during the first year of COVID-19.But the warning is more ominous with the continual emergence of variants of the coronavirus that have differing characteristics-transmission speed,pathogenicity,evasion of immunity to prior infection or immunization(1). 展开更多
关键词 IMMUNITY PRESCRIPTION STATEMENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部